All Stories

  1. Persistent Smell and Taste Disorders in the Post‐COVID‐19 Pandemic Era: A Cross‐National Study of Prevalence and Quality of Life in the UK and the USA
  2. COPANOS: use of gabapentin in the management of post-viral parosmia – a double-blind, randomised, placebo-controlled, multi-site trial – study protocol
  3. Comparing Quality of Life in Smell and Taste Disorders With Other Chronic Conditions—A Narrative Review
  4. Acute rhinosinusitis
  5. Rhinosinusitis: Definitions, classification and diagnosis
  6. The Norfolk Smell and Taste Clinic Experience—A Decade of Olfactory and Gustatory Dysfunction
  7. Self-Reported Smell and Taste Disorders in the General Population: A Cross-Sectional Survey in Austria, Germany and Switzerland
  8. Smell and Taste Disorder Impact on Eating Habits: A Cross‐Sectional Observational Study
  9. Chronic rhinosinusitis: a qualitative study of patient and clinician experiences of the MACRO randomised controlled trial of surgical versus medical management
  10. Comparing quality of life in smell and taste disorders with other chronic conditions – a narrative review
  11. Investigating the Effect of Tumour Necrosis Factor Antagonist on Olfaction
  12. A Cross‐Sectional Study Exploring Patient Experiences, Unmet Needs and Desired Support in Those With Olfactory Dysfunction
  13. A Prospective Cohort Study Investigating the Role of a Screening Smell and Taste Test in Patients Following Head Injury
  14. The APOLLO Trial: A P roof-of-Concept Study for Vitamin A Nasal Drops in COVID-19 Related Post-Infectious Ol factory Dysfunction
  15. Digital intervention for smell training: a real-world study on engagement, adherence, and behavioural dynamics
  16. Investigating idiopathic anosmia as a prodromal state of Parkinson’s disease
  17. The need to promote smell health across the globe
  18. Endoscopic Management of Sinus Neoplasia: An Experience of a Dedicated Sinus Centre in Image-Guided Surgery of Inverted Papillomata
  19. A trial comparing sinus surgery and antibiotics in adults with chronic rhinosinusitis
  20. The need to promote smell health across the globe
  21. Exploring barriers to seeking support for Smell and Taste Disorders (SATDs) amongst minority communities in the UK
  22. Gustatory dysfunction in dementia and cognitive decline
  23. Olfactory loss and dysfunction in dementia and cognitive decline
  24. A New Approach to Dementia
  25. \fancyhead [R] Smell and Taste Disorder Impact on Eating Habits: a cross-sectional observational study
  26. The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
  27. Epidemiology of Cholesteatoma in the UK Biobank
  28. British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
  29. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control
  30. Epidemiology of Cholesteatoma in the UK Biobank
  31. Smell Above All: Envisioning Smell-Centred Future Worlds
  32. Impact of olfactory disorders on personal safety and well-being: a cross-sectional observational study
  33. Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
  34. The Clinical Course of Paranasal Sinus Mucocoeles—A Retrospective Case Series
  35. Obesity and Olfaction
  36. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Hybrid Posters
  37. International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction
  38. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
  39. Delivery of Topical Drugs to the Olfactory Cleft
  40. Endoscopic management of sinus neoplasia: case series of image-guided surgery of inverted papillomata and recommended best practice for managing cases.
  41. Everything smells like poo, landfill, and rotten food”: A retrospective case report using Clinical Emotional Freedom Techniques (EFT) for parosmia following COVID-19
  42. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
  43. Position paper on olfactory dysfunction: 2023
  44. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study
  45. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  46. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  47. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  48. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  49. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  50. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  51. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  52. Nose Gym: An Interactive Smell Training Solution
  53. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  54. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  55. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  56. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  57. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  58. The Nose and the Effects of SARS-CoV-2 Pandemic
  59. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  60. The EUFOREA pocket guide for chronic rhinosinusitis
  61. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  62. Investigations and Outcomes for Olfactory Disorders
  63. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  64. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  65. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  66. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  67. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  68. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  69. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  70. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  71. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  72. A Double Blinded Randomised Controlled Trial of Vitamin a Drops to Treat Post-viral Olfactory Loss: Study Protocol for a Proof-of-concept Study for Vitamin a Nasal Drops in Post-viral Olfactory Loss (Apollo)
  73. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  74. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  75. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  76. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  77. International consensus statement on allergy and rhinology: Olfaction
  78. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  79. Interventions for the treatment of persistent post-viral olfactory dysfunction
  80. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  81. Olfaction and CSF Leak
  82. The Growing Burden of Long COVID in the United Kingdom - Insights from the UK Coronavirus Infection Survey
  83. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  84. Increasing incidence of parosmia and phantosmia in patients recovering from COVID-19 smell loss
  85. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  86. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  87. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  88. Barriers to effective health care for patients who have smell or taste disorders
  89. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  90. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  91. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  92. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  93. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  94. Biologics for chronic rhinosinusitis
  95. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  96. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  97. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  98. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  99. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  100. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  101. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  102. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  103. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  104. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  105. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  106. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  107. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  108. Patient Experiences of Postinfectious Olfactory Dysfunction
  109. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  110. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  111. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  112. Comparison of COVID-19 and common cold chemosensory dysfunction
  113. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  114. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  115. Patient Experiences of Post-Infectious Olfactory Dysfunction
  116. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  117. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  118. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  119. Olfactory Loss of Function as a Possible Symptom of COVID-19
  120. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  121. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  122. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  123. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  124. Qualitative Olfactory Disorders: Patient experiences and self-management
  125. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  126. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  127. Parosmia is associated with relevant olfactory recovery after olfactory training
  128. More than smell - COVID-19 is associated with severe impairment of smell, taste, and chemesthesis
  129. The impact of patients losing their sense of smell
  130. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  131. Post-Viral Olfactory Loss: A Survey of One Hundred and Twenty Patient Experiences
  132. Cholesteatoma and family history: An international survey
  133. Is loss of sense of smell as a diagnostic marker in COVID-19: A Systematic Review and Meta-analysis
  134. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  135. Biologics for chronic rhinosinusitis
  136. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  137. Smoking as a Modifying Factor in Chronic Rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study
  138. Biologics for chronic rhinosinusitis
  139. An unmet need: Patients with smell and taste disorders
  140. 139 Risk of parkinson’s in idiopathic anosmia
  141. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  142. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  143. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  144. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  145. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  146. What is the most appropriate treatment for chronic rhinosinusitis?
  147. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  148. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  149. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  150. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  151. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  152. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  153. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  154. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  155. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  156. Wooden spatula sinusitis following maxillary expansion surgery
  157. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  158. Topical and systemic antifungal therapy for chronic rhinosinusitis
  159. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  160. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  161. Saline irrigation for allergic rhinitis
  162. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  163. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  164. Endonasal Approaches to Maxillary Sinus
  165. The use of nasal sprays and rinses in patients with chronic sinus disease
  166. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  167. Initial assessment in the management of adult epistaxis: systematic review
  168. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  169. Health care usage and quality of life reporting in chronic sinusitis patients
  170. The genetics of cholesteatoma. A systematic review using narrative synthesis
  171. Position paper on olfactory dysfunction
  172. Chronic rhinosinusitis and mood disturbance
  173. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  174. Saline irrigation for allergic rhinitis
  175. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  176. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  177. Position paper on olfactory dysfunction
  178. Chronic rhinosinusitis and mood disturbance
  179. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  180. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  181. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  182. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  183. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  184. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  185. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  186. Topical and systemic antifungal therapy for chronic rhinosinusitis
  187. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  188. SNOT-22 in a control population
  189. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  190. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  191. Genetics of Cholesteatoma Project
  192. Short-course oral steroids alone for chronic rhinosinusitis
  193. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  194. Different types of intranasal steroids for chronic rhinosinusitis
  195. Systemic and topical antibiotics for chronic rhinosinusitis
  196. Saline irrigation for chronic rhinosinusitis
  197. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  198. Chronic rhinosinusitis and mood disturbance
  199. Long term quality of life in patients with fungal sinus disease
  200. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  201. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  202. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  203. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  204. Systemic and topical antibiotics for chronic rhinosinusitis
  205. Saline irrigation for chronic rhinosinusitis
  206. Different types of intranasal steroids for chronic rhinosinusitis
  207. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  208. Short-course oral steroids alone for chronic rhinosinusitis
  209. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  210. The impact of commissioning for rhinosinusitis in England
  211. Investigation of nasal diseases
  212. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  213. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  214. Authors’ response
  215. Hyposmia
  216. Assessing the sense of smell
  217. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  218. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  219. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  220. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  221. The Impact of Olfactory Disorders in the United Kingdom
  222. Chronic Rhinosinusitis and Mood Disturbance
  223. Management of CRSwNPs Surgically
  224. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  225. SNOT-22 in a Control Population
  226. Anatomy and Physiology of the Olfactory and Gustatory Systems
  227. Cerebrospinal Fluid Rhinorrhoea
  228. Ciliary Motility Disorders
  229. Clinical Governance and Audit
  230. Complications of Sinusitis
  231. Endoscopic Sinus Surgery and Complications
  232. Epistaxis
  233. European Position Paper on Rhinosinusitis and Nasal Polyps
  234. Facial Flaps, Scars, and Keloids
  235. Facial Fractures and Swelling
  236. Fungal Sinus Disease
  237. Headache and Facial Pain
  238. Medical Statistics
  239. Microbiology of ENT
  240. Olfactory and Gustatory Disorders
  241. Sinonasal Anatomy and Physiology
  242. Tumours of the Nose and Paranasal Sinuses
  243. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  244. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  245. Unilateral cacosmia: a presentation of maxillary fungal infestation
  246. When mealtime is the most dreaded moment of your day
  247. Pneumatisation of turbinates and paranasal sinuses in children: case report
  248. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  249. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  250. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  251. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  252. A useful tool - systematic checklist for evaluating sinus scans
  253. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  254. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  255. Allergic fungal rhinosinusitis - a new staging system
  256. Allergic fungal rhinosinusitis - a new staging system
  257. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  258. Selecting the Best Approach to the Frontal Sinus
  259. Nanomedicine in otorhinolaryngology: what does the future hold?
  260. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  261. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  262. Tumefactive fibroinflammatory lesion of the frontal sinus
  263. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  264. SUBJECTS AND METHODS
  265. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  266. Proximal Lacrimal Obstruction – A Review
  267. The superosmic phenomenon
  268. The Leicester Olfactometer
  269. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  270. ENT cases seen at a local ‘walk-in centre’: a one year review
  271. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  272. A brief history of olfaction and olfactometry
  273. The superosmic phenomenon
  274. Olfactory clearance: what time is needed in clinical practice?
  275. The Effect of Female Hormone Manipulation on Nasal Physiology
  276. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  277. R152: Olfactory Adaptation and Clearance in Clinical Practice
  278. Bronchiectasis and sino-nasal disease: a review
  279. What is the short term effect of perfumes on olfactory thresholds?
  280. Which variables matter in smell tests in the clinic?
  281. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  282. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  283. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  284. Comparison of Subjective Perception with Objective Measurement of Olfaction
  285. Response to Rachmanidou
  286. A double‐blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on postoperative symptoms
  287. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  288. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  289. Do our Noses Lead Us Away from the Scent?
  290. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  291. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  292. Is there a role for more day-case septal surgery?
  293. Erratum
  294. Canalicular adenoma of the parotid gland
  295. Paediatric retropharyngeal abscess
  296. Which solvent for olfactory testing?
  297. Nasal physiological changes during pregnancy
  298. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  299. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  300. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  301. Subjects and methods
  302. Hyposmia